Finding 611784 (2022-002)

Significant Deficiency
Requirement
P
Questioned Costs
-
Year
2022
Accepted
2023-10-01
Audit: 24187
Auditor: Forvis LLP

AI Summary

  • Core Issue: Inadequate controls over the preparation of the Schedule of Expenditures led to omissions of approximately $480,000 in MMC-Dickinson expenditures.
  • Impacted Requirements: Compliance with 2 CFR 200.303(a) regarding effective internal controls over federal awards was not met.
  • Recommended Follow-Up: Management should enhance controls to ensure timely and accurate inclusion of all expenditures, especially for new acquisitions like MMC-Dickinson.

Finding Text

Finding 2022-002 - Preparation of the Schedule of Expenditures of Federal Awards Department of Treasury COVID-19 - Coronavirus State and Local Fiscal Recovery Funds Assistance Listing #21.027 Significant Deficiency Criteria: Title 2 Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) requires the System to prepare a schedule of expenditures of federal awards (Schedule). 2 CFR 200.303(a) establishes that the auditee must establish and maintain effective internal control over the federal award in compliance with federal statutes, regulations, and conditions of the federal award. Condition: Inadequate controls exist over the preparation of the Schedule specific to expenditure activity for the MMC- Dickinson subsidiary that was acquired in 2022 to allow for the timely completion of a complete and accurate Schedule. Consequently, certain MMC Dickinson expenditures were erroneously omitted from the preliminary Schedule. Cause: The System acquired MMC-Dickinson during 2022 and has not yet fully implemented existing System internal controls to the new subsidiary. Effect: Management identified additional MMC-Dickinson expenditures that were added to the Schedule late in the audit process. Questioned costs: None reported. Context: Approximately $480,000 of expenditures in relations to total expenditures of approximately $800,000 under assistance listing number 21.027 COVID-19 Coronavirus State and Local Fiscal Recovery Funds for the year-ended December 31, 2022, were originally omitted from the preliminary Schedule. Additionally, approximately $665,000 in expenditures from other programs was originally omitted from the preliminary Schedule and approximately $345,000 of expenditures were removed from the preliminary Schedule. These changes were not identified in a timely manner resulting in delays in completing the System Single Audit. Repeat finding from prior year: Not for the System but Yes, for 2021 Single Audit of MMC-Dickinson See prior year finding 2021-003. Recommendation: We recommend that management enhance its controls over the Schedule to ensure they include MMC-Dickinson and future acquisition to ensure timely accurate completion of the Schedule. Views of responsible officials and planned corrective actions: Management agrees with this finding. Please refer to pages 64 and 65 for the Corrective Action Plan

Categories

Allowable Costs / Cost Principles Reporting Significant Deficiency Internal Control / Segregation of Duties

Other Findings in this Audit

  • 35340 2022-004
    Significant Deficiency
  • 35341 2022-003
    Significant Deficiency
  • 35342 2022-002
    Significant Deficiency
  • 611782 2022-004
    Significant Deficiency
  • 611783 2022-003
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.498 Provider Relief Fund $28.34M
10.766 Community Facilities Loans and Grants $16.77M
93.399 Cancer Control $3.21M
94.006 Americorps $1.81M
93.350 National Center for Advancing Translational Sciences $683,873
93.859 Biomedical Research and Research Training $663,551
32.006 Covid-19 Telehealth Program $654,939
93.310 Trans-Nih Research Support $638,303
93.912 Rural Health Care Services Outreach, Rural Health Network Development and Small Health Care Provider Quality Improvement $572,566
16.575 Crime Victim Assistance $432,867
93.959 Block Grants for Prevention and Treatment of Substance Abuse $412,533
93.697 Covid-19 Testing for Rural Health Clinics $322,578
93.155 Rural Health Research Centers $257,853
93.211 Telehealth Programs $222,082
93.788 Opioid Str $210,993
93.396 Cancer Biology Research $204,974
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $191,624
93.866 Aging Research $100,410
93.393 Cancer Cause and Prevention Research $80,574
10.001 Agricultural Research_basic and Applied Research $60,097
93.279 Drug Abuse and Addiction Research Programs $48,148
93.243 Substance Abuse and Mental Health Services_projects of Regional and National Significance $48,024
93.426 Improving the Health of Americans Through Prevention and Management of Diabetes and Heart Disease and Stroke $35,769
93.575 Child Care and Development Block Grant $31,975
93.394 Cancer Detection and Diagnosis Research $31,127
93.172 Human Genome Research $27,301
93.241 State Rural Hospital Flexibility Program $20,000
93.898 Cancer Prevention and Control Programs for State, Territorial and Tribal Organizations $17,024
93.262 Occupational Safety and Health Program $13,860
10.212 Small Business Innovation Research $12,500
93.301 Small Rural Hospital Improvement Grant Program $11,790
12.420 Military Medical Research and Development $11,000
47.041 Engineering $9,786
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $8,700
93.865 Child Health and Human Development Extramural Research $6,075
93.421 Strengthening Public Health Systems and Services Through National Partnerships to Improve and Protect the Nations Health $3,406
93.307 Minority Health and Health Disparities Research $2,673
21.027 Coronavirus State and Local Fiscal Recovery Funds $2,513
93.435 Innovative State and Local Public Health Strategies to Prevent and Manage Diabetes and Heart Disease and Stroke- $1,166
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $1,111
93.185 Immunization Research, Demonstration, Public Information and Education_training and Clinical Skills Improvement Projects $764
93.855 Allergy, Immunology and Transplantation Research $463
10.303 Integrated Programs $297
93.837 Cardiovascular Diseases Research $57
93.268 Immunization Cooperative Agreements $40